Lyon, 25–27 January 2017 Auditorium

Scientific Council
Fifty-third Session
SC/53/11
20/04/2017
Lyon, 25–27 January 2017
Auditorium
LIST OF MEMBERS AND OTHER PARTICIPANTS
Scientific Council members
Professor Ellen Kampman (Chair)
Chair Nutrition and Disease
Wageningen University
Division of Human Nutrition
PO Box 17
NL 6700 AA Wageningen
The Netherlands
E-mail: [email protected]
Professor Giske Ursin (Vice-Chair)
Director
Cancer Registry of Norway
PB 5313 Majorstuen
0304 Oslo, Norway
E-mail: [email protected]
Professor Elisabete Weiderpass Vainio
(Rapporteur)
Group Leader
Program on Genetic Research
Genetic Epidemiology Group
Folkhälsan Research Center, Biomedicum 1
Haartmansgatan 8, PB 63 (C321b)
FI-00014 University of Helsinki, Finland
E-mail: [email protected]
Dr Boris Ya. Alekseev
Deputy Director for Scientific Affairs
Federal Medical Research Centre named after
P.A. Gertsen
3-2d Botkinskiy proezd
Moscow 125284, Russian Federation
E-mail: [email protected]
Dr Al-Hareth M. Al-Khater
Deputy Medical Director, National Center for
Cancer Care & Research
Hamad Medical Corporation
PO Box 3050
Doha, Qatar
E-mail: [email protected]
Professor Jonas Bergh
Karolinska Institutet
Byggnad Z1:01
Solna 171 76 Stockholm, Sweden
E-mail: [email protected]
Professor Jenny Chang-Claude
Head, Unit of Genetic Epidemiology
German Cancer Research Center (DKFZ)
Im Neuenheimer Feld 280
69120 Heidelberg, Germany
E-mail: [email protected]
Professor Stephen J. Chanock
Director, Division of Cancer Epidemiology
and Genetics
National Cancer Institute
9609 Medical Center Drive
MSC 9776
Bethesda, MD 20892, USA
E-mail: [email protected]
Scientific Council
List of Members and other participants
Professor Françoise Clavel-Chapelon
Director, “Nutrition, hormones and women’s
health”
INSERM U1018
114 rue Edouard Vaillant
F 94800 Villejuif
E-mail: [email protected]
SC/53/11
Page 2
Professor Kadir Mutlu Hayran
Hacettepe University
Cancer Institute
Department of Preventive Oncology
06100 Ankara, Turkey
E-mail: [email protected]
Dr Jerome Coffey
The National Cancer Control Programme
King’s Inns House
200 Parnell Street,
Dublin 1, Ireland
Professor Lukas A. Huber (unable to attend)
Director, Biocenter and Cell Biology Division
Medical University Innsbruck
Innrain 80–82
A 6020 Innsbruck
Austria
E-mail: [email protected]
E-mail: [email protected]
Dr Eugenia Dogliotti
Laboratory of Applied Toxicology
Istituto Superiore di Sanità
Department of Environmental and Primary
Prevention
Viale Regina Elena 299
I 00161 Rome
Professor Lalit Kumar
Department of Medical Oncology
Room 234, 2nd Floor
Dr Brambedkar Institute Rotary Cancer
Hospital
All India Institute of Medical Sciences
(AIIMS)
New Delhi 11 00 29, India
E-mail: [email protected]
Professor Karima El Rhazi
Department of Epidemiology and Public
Health
Faculty of Medicine of Fez
BP 1893
Fez, Morocco
E-mail: [email protected]
Professor Adèle Green
Senior Scientist
QIMR Berghofer Medical Research Institute
300 Herston Road
Herston QLD 4006, Australia
E-mail: [email protected]
E-mail: [email protected]
Dr Dukhyoung Lee
Director
National Cancer Control Institute
National Cancer Center Korea
323 Ilsan-ro, Ilsandong-gu, Goyang-si
Gyeonggi-do 10408, Republic of Korea
E-mail: [email protected]
Professor Atsushi Ochiai
Director, Exploratory Oncology Research and
Clinical Trial Center
National Cancer Center
5-1-1 Tsukiji, Chuo-ku
Tokyo 104-0045, Japan
E-mail: [email protected]
SC/53/11
Page 3
Scientific Council
List of Members and other participants
Professor Ole Raaschou-Nielsen
Danish Cancer Society
Department of Work, Environment and
Cancer
Strandboulevarden 49
DK 2100 Copenhagen Ø
Dr Pilar Sánchez Gómez
Head, Neurooncology Unit
Chronic Disease Program
Instituto de Salud Carlos III
C/ Monforte de Lemos 5
E 28029 Madrid
E-mail: [email protected]
E-mail: [email protected]
Dr Luis Felipe Ribeiro Pinto
Deputy Director General
Head of Molecular Carcinogenesis Program
Head of Education
Brazilian National Cancer Institute (INCA)
Rua André Cavalcanti, 37 – Centro
20231-050 Rio de Janeiro, RJ, Brazil
Professor John J. Spinelli
Vice President, Population Oncology
BC Cancer Agency
6th floor West – 750 W. Broadway
Vancouver, BC, V5Z 1H5, Canada
E-mail: [email protected]
Professor Martin Röösli
Swiss Tropical and Public Health Institute,
Basel
Socinstrasse 59
CH 4002 Basel
E-mail: [email protected]
Dr Roberto Salgado
Breast Cancer Translational
Laboratory
Jules Bordet Institute
Boulevard de Waterloo 121
B 1000 Brussels
E-mail: [email protected]
Professor Simon Tavaré
Director
Cancer Research UK Cambridge Institute
University of Cambridge
Li Ka Shing Centre, Robinson Way
GB Cambridge CB2 0RE
E-mail: [email protected]
Research
E-mail: [email protected]
Governing Council
Dr Mark Palmer, Chairperson
Head, International Strategy
Medical Research Council
14th floor, One Kemble Street
GB London WC2B 4AN
E-mail: [email protected]
Professor Mads Melbye, Vice-Chairperson
(unable to attend)
Director, Statens Serum Institute
Artillerivej 5
2300 Copenhagen S
E-mail: [email protected]
Scientific Council
List of Members and other participants
SC/53/11
Page 4
WHO, Geneva
Dr Andreas Ullrich
Senior Advisor to ADG/NMH
IARC Liaison Officer
World Health Organization
CH 1211 Geneva 27
E-mail: [email protected]
UICC
No representative
IARC Ethics Committee
Professor Béatrice Fervers
Chair, IARC Ethics Committee
E-mail: [email protected]
Observer
Dr David Cox
Research Associate, INSERM U1052
Centre Léon Bérard
28 rue Laënnec
F 69373 Lyon Cedex 08
E-mail: [email protected]
IARC Secretariat
Dr Christopher P. Wild, Director